logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > White Powder 5-iodo-2'-deoxyuridine CAS 54-42-2

White Powder 5-iodo-2'-deoxyuridine CAS 54-42-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 54-42-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

5-iodo-2'-deoxyuridine CAS 54-42-2

,

CAS 54-42-2

CAS NO::
54-42-2
Appearance::
White Powder
Molecular Formula::
C9H11IN2O5
Molecular Weight::
354.09900
EINECS NO::
200-207-8
MDL NO::
MFCD00134656
CAS NO::
54-42-2
Appearance::
White Powder
Molecular Formula::
C9H11IN2O5
Molecular Weight::
354.09900
EINECS NO::
200-207-8
MDL NO::
MFCD00134656
White Powder 5-iodo-2'-deoxyuridine CAS 54-42-2

Product Description:

Product Name: 5-iodo-2'-deoxyuridine CAS NO: 54-42-2

 

 

Synonyms:

1-beta-d-2’-deoxyribofuranosyl-5-iodouracil;

2’-deoxy-5-iodo-uridin;

5-Iodouracil deoxyriboside;

 

 

Chemical & Physical Properties:

Appearance: White powder

Assay :≥99.0%

Density: 2.14g/cm3

Melting Point: 155-180℃

Refractive Index: 30 ° (C=1, 1mol/L NaOH)

Water Solubility: 1.6 g/L (20℃)

Stability: Stable under normal temperatures and pressures

Storage Condition: 2-8℃

Sensitive: Air & Light sensitive

 

 

Safety Information:

RTECS: YU7700000

Hazard Codes: T,Xn

HS Code: 2934999090

WGK Germany: 3

Risk Statements: R45; R46; R61

Safety Statements: S53-S45

 

 

Idoxuridine is an anti-herpesvirus antiviral drug.

It is a nucleoside analogue, a modified form of deoxyuridine, similar enough to be incorporated into viral DNA replication, but the iodine atom added to the uracil component blocks base pairing. It is used only topically due to cardiotoxicity. It was synthesized by William Prusoff in the late 1950s. Initially developed as an anticancer drug, idoxuridine became the first antiviral agent in 1962.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.